SOC ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
47バージャー病1

47. バージャー病


臨床試験数 : 9 薬物数 : 14 - (DrugBank : 7) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 16
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02501018
(ClinicalTrials.gov)
November 1, 201714/7/2015Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)A Prospective, Open Label, Controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI) Due to Arteriosclerosis Obliterans (ASO) With a Single-arm Substudy to Assess the Safety and Potential Efficacy of CLBS12 in Patients With CLI Due to Buerger's Disease (BD)Critical Limb Ischemia;Buerger Disease;Thromboangiitis Obliterans;Atherosclerosis ObliteransBiological: CLBS12;Drug: SOCLisata Therapeutics, Inc.NULLCompleted20 Years85 YearsAll33Phase 2Japan